Company ProfilePremium

Zymergen

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
Zymergen - Healthcare showcase

Year Founded & Workforce

2013

500 Employees

Industry

Healthcare

Services

Nanobots
Z

Zymergen Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Zymergen Overview

Company Headquarters: Emeryville, US

Founded: 2013

Workforce: ~201–500

Company Working: Zymergen is a biotechnology and pharmaceutical company engaged in R&D, manufacturing, and marketing of novel products and materials for the agricultural, chemical, materials, pharmaceutical, electronics, and personal care industries. The company operates through two business segments, namely technology and solutions. It uses artificial intelligence, big data, bioinformatics, machine learning, and robotic tools for the development of innovative microbes. The company has an additional office in Washington. It has raised more than USD 500 million in the last 5 years through more than 23 investors by multiple rounds of funding.

Strategy

Zymergen is focusing on the development of innovative products through R&D and to cater to the demand in the pharmaceutical, agricultural, chemical, and other industries. It also aims at raising maximum funds for research and development by conducting multiple rounds of investment events.

Company Snapshot

500

Employees

2013

Founded

Emeryville, US

Headquarters

SWOT Analysis

Strengths

  • Offers unique products
  • Skilled workforce
  • High focus on R&D

Weaknesses

  • Dependent on grants and funds

Opportunities

  • Mergers and acquisitions
  • Development of innovative products

Threats

  • Fluctuation in currency exchange rates
  • As its products are in clinical trial phase, stringent government policies can hamper product launch

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateApproachDevelopment
January 2018AcquisitionZymergen acquired Radiant Genomics for an undisclosed amount. With this acquisition, Zymergen will be able to use sequencing, bioinformatics, synthetic biology, and other technologies of Radiant for natural product discovery, diversification, and production purposes.

Product Offering

  • Zymergen
    • Nanobots

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.